Temporary mechanical circulatory support in patients with cardiogenic shock: current status and future perspectives

Abstract

Mechanical circulatory support (MCS) devices provide hemodynamic assistance in patients with severe heart failure or shock. Use of temporary MCS has increased dramatically in recent years despite the lack of high-quality evidence, with their use generally based on expert consensus.There is no single treatment that is suitable for every patient with cardiogenic shock, as the clinical condition varies among patients and also changes rapidly. Therefore, use of MCS should be tailored based on the severity, phenotype, and phase of the disease in each individual patient.Future studies are needed to clarify the factors that can enable matching of “the right MCS to the right patient at the right time.”